Groups: CMS Has Tools To Fix IRA Formulary Issues That Limit Part D Savings To Patients

By Sigi Ris / July 12, 2024 at 1:46 PM

CMS has tools at its disposal to protect Part D beneficiaries from insurance policies the drug industry lobby says could limit patients’ ability to benefit from lower prices negotiated under the Inflation Reduction Act (IRA), according to a report from the Alliance of Aging Research and Manatt.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.